فانجارد بلس 5 إل 4 سي في لقاح الكلاب الشامل للوقاية من الدستمبر والبارفو والكورونا والليبتوسبيرا الرباعية
Vanguard Plus 5 L4 CV is a multi-component vaccine containing modified-live cultures of canine distemper, adenovirus type 2 (CAV-2), parainfluenza, and high-titer parvovirus (CPV-2b), inactivated canine coronavirus, and whole-cell inactivated bacterins of Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona. Indicated for the vaccination of healthy dogs 6 weeks of age or older.
Dosage Form
N/A
Product Type
Biological
Manufacturer
Package
Cartons of 25 x 1-dose vials with sterile liquid diluent (1 mL each)
No dosage information available.
No withdrawal information available.
Vaccination of healthy dogs 6 weeks of age or older as an aid in preventing canine distemper, infectious canine hepatitis (CAV-1), respiratory disease (CAV-2), canine coronavirus, canine parainfluenza, canine parvovirus (CPV-2b), and leptospirosis (L. canicola, L. grippotyphosa, L. icterohaemorrhagiae, L. pomona).
No contraindications information available.
Contains gentamicin as preservative. Epinephrine should be administered if anaphylaxis occurs.
Mild temporary pain or swelling at the injection site; transient lethargy.
Vanguard Plus 5 L4 CV Canine Multi-Antigen Vaccine Prescribing Information
LeafletNo diseases linked.
No data available
Information has not been added yet.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.